nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—TP53—ocular cancer	0.75	1	CbGaD
Acetylsalicylic acid—TP53—skull—ocular cancer	0.00968	0.239	CbGeAlD
Acetylsalicylic acid—HSPA5—pineal body—ocular cancer	0.00676	0.167	CbGeAlD
Acetylsalicylic acid—NFKBIA—eye—ocular cancer	0.0021	0.0518	CbGeAlD
Acetylsalicylic acid—NFKBIA—retina—ocular cancer	0.00208	0.0513	CbGeAlD
Acetylsalicylic acid—HSPA5—eye—ocular cancer	0.00205	0.0507	CbGeAlD
Acetylsalicylic acid—HSPA5—retina—ocular cancer	0.00204	0.0503	CbGeAlD
Acetylsalicylic acid—TP53—epithelium—ocular cancer	0.00195	0.0482	CbGeAlD
Acetylsalicylic acid—NFKBIA—epithelium—ocular cancer	0.00192	0.0474	CbGeAlD
Acetylsalicylic acid—HSPA5—epithelium—ocular cancer	0.00188	0.0464	CbGeAlD
Acetylsalicylic acid—RPS6KA3—retina—ocular cancer	0.00173	0.0428	CbGeAlD
Acetylsalicylic acid—TP53—lymphoid tissue—ocular cancer	0.0015	0.0371	CbGeAlD
Acetylsalicylic acid—NFKBIA—lymphoid tissue—ocular cancer	0.00148	0.0365	CbGeAlD
Acetylsalicylic acid—HSPA5—lymphoid tissue—ocular cancer	0.00145	0.0357	CbGeAlD
Acetylsalicylic acid—RPS6KA3—lymphoid tissue—ocular cancer	0.00123	0.0304	CbGeAlD
Acetylsalicylic acid—IKBKB—lymphoid tissue—ocular cancer	0.00091	0.0225	CbGeAlD
Acetylsalicylic acid—PTGS1—epithelium—ocular cancer	0.000393	0.00971	CbGeAlD
Acetylsalicylic acid—PTGS2—epithelium—ocular cancer	0.000376	0.00928	CbGeAlD
Acetylsalicylic acid—PTGS2—lymphoid tissue—ocular cancer	0.000289	0.00715	CbGeAlD
Acetylsalicylic acid—ABCB1—retina—ocular cancer	0.000252	0.00622	CbGeAlD
Acetylsalicylic acid—ABCB1—epithelium—ocular cancer	0.000232	0.00574	CbGeAlD
Acetylsalicylic acid—ABCB1—lymphoid tissue—ocular cancer	0.000179	0.00442	CbGeAlD
Acetylsalicylic acid—EDNRA—Signaling Pathways—GNAQ—ocular cancer	2.54e-05	0.000122	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—GNAQ—ocular cancer	2.54e-05	0.000122	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—HDAC1—ocular cancer	2.54e-05	0.000121	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—E2F5—ocular cancer	2.54e-05	0.000121	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—C-MYB transcription factor network—HRAS—ocular cancer	2.52e-05	0.000121	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—BDNF signaling pathway—HRAS—ocular cancer	2.51e-05	0.00012	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—E2F4—ocular cancer	2.48e-05	0.000119	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PSPH—ocular cancer	2.45e-05	0.000117	CbGpPWpGaD
Acetylsalicylic acid—TP53—Cell Cycle—MYC—ocular cancer	2.45e-05	0.000117	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—MYC—ocular cancer	2.45e-05	0.000117	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—TGFB1—ocular cancer	2.44e-05	0.000117	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—RBL1—ocular cancer	2.44e-05	0.000116	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—EP300—ocular cancer	2.43e-05	0.000116	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—CDKN1B—ocular cancer	2.41e-05	0.000115	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	2.41e-05	0.000115	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PSPH—ocular cancer	2.39e-05	0.000114	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—TGFB1—ocular cancer	2.39e-05	0.000114	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—TGFB1—ocular cancer	2.38e-05	0.000114	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	2.38e-05	0.000114	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—E2F5—ocular cancer	2.36e-05	0.000113	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—TP53—ocular cancer	2.32e-05	0.000111	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—E2F4—ocular cancer	2.32e-05	0.000111	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Insulin Signaling—HRAS—ocular cancer	2.31e-05	0.00011	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CDKN2B—ocular cancer	2.3e-05	0.00011	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HDAC1—ocular cancer	2.29e-05	0.00011	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HDAC1—ocular cancer	2.29e-05	0.00011	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—ocular cancer	2.28e-05	0.000109	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	2.28e-05	0.000109	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—MDM2—ocular cancer	2.27e-05	0.000109	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CDKN2B—ocular cancer	2.27e-05	0.000109	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—RBL1—ocular cancer	2.27e-05	0.000109	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—RPL39—ocular cancer	2.27e-05	0.000109	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PSPH—ocular cancer	2.24e-05	0.000107	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—ocular cancer	2.23e-05	0.000106	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—CDKN1A—ocular cancer	2.22e-05	0.000106	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—BDNF signaling pathway—AKT1—ocular cancer	2.21e-05	0.000106	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	2.17e-05	0.000104	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—ocular cancer	2.13e-05	0.000102	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—GNA11—ocular cancer	2.12e-05	0.000101	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—E2F3—ocular cancer	2.11e-05	0.000101	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—E2F1—ocular cancer	2.11e-05	0.000101	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—E2F1—ocular cancer	2.09e-05	9.97e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—CDKN1B—ocular cancer	2.08e-05	9.93e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	2.07e-05	9.92e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CDKN2B—ocular cancer	2.06e-05	9.82e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CDKN2B—ocular cancer	2.06e-05	9.82e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Hemostasis—HRAS—ocular cancer	2.04e-05	9.75e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Insulin Signaling—AKT1—ocular cancer	2.04e-05	9.73e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—TP53—ocular cancer	2.01e-05	9.6e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	2.01e-05	9.59e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—MDM2—ocular cancer	1.97e-05	9.43e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—GNAQ—ocular cancer	1.97e-05	9.43e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Activation—HRAS—ocular cancer	1.97e-05	9.41e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—ocular cancer	1.97e-05	9.4e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TFDP1—ocular cancer	1.96e-05	9.38e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—AKT1—ocular cancer	1.96e-05	9.36e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—CDKN1A—ocular cancer	1.92e-05	9.16e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	1.91e-05	9.15e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	1.91e-05	9.13e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—E2F1—ocular cancer	1.89e-05	9.02e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—E2F1—ocular cancer	1.89e-05	9.02e-05	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—HRAS—ocular cancer	1.88e-05	9.01e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—HRAS—ocular cancer	1.88e-05	8.99e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—ocular cancer	1.88e-05	8.97e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—HRAS—ocular cancer	1.86e-05	8.88e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TFDP1—ocular cancer	1.83e-05	8.75e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—EP300—ocular cancer	1.82e-05	8.72e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Hemostasis—AKT1—ocular cancer	1.8e-05	8.61e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CDKN1B—ocular cancer	1.8e-05	8.61e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—HRAS—ocular cancer	1.78e-05	8.53e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—HDAC1—ocular cancer	1.78e-05	8.5e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—MDM2—ocular cancer	1.76e-05	8.43e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Activation—AKT1—ocular cancer	1.74e-05	8.3e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	1.69e-05	8.07e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	1.66e-05	7.95e-05	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—AKT1—ocular cancer	1.66e-05	7.95e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CDKN1A—ocular cancer	1.66e-05	7.94e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—HRAS—ocular cancer	1.66e-05	7.94e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—AKT1—ocular cancer	1.66e-05	7.94e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	1.66e-05	7.93e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—AKT1—ocular cancer	1.64e-05	7.84e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CDKN1B—ocular cancer	1.61e-05	7.69e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—MDM2—ocular cancer	1.59e-05	7.61e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—MYC—ocular cancer	1.59e-05	7.6e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—TGFB1—ocular cancer	1.59e-05	7.58e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—EP300—ocular cancer	1.58e-05	7.56e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—AKT1—ocular cancer	1.58e-05	7.53e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MAML2—ocular cancer	1.56e-05	7.45e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	1.54e-05	7.37e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—EP300—ocular cancer	1.53e-05	7.3e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—MDM2—ocular cancer	1.51e-05	7.2e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CDKN1A—ocular cancer	1.49e-05	7.1e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—HRAS—ocular cancer	1.47e-05	7.04e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	1.47e-05	7.03e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—AKT1—ocular cancer	1.47e-05	7.01e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MAML2—ocular cancer	1.45e-05	6.95e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CDKN1B—ocular cancer	1.45e-05	6.95e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—HRAS—ocular cancer	1.45e-05	6.92e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—MDM2—ocular cancer	1.45e-05	6.91e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	1.42e-05	6.8e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—EP300—ocular cancer	1.41e-05	6.76e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CCND1—ocular cancer	1.39e-05	6.63e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CDKN1B—ocular cancer	1.37e-05	6.57e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	1.37e-05	6.53e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—GNA11—ocular cancer	1.36e-05	6.5e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	1.35e-05	6.47e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CDKN1A—ocular cancer	1.34e-05	6.42e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GNA11—ocular cancer	1.34e-05	6.4e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CDKN1B—ocular cancer	1.32e-05	6.31e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—AKT1—ocular cancer	1.28e-05	6.11e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—EP300—ocular cancer	1.28e-05	6.1e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MDM2—ocular cancer	1.28e-05	6.1e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CDKN1A—ocular cancer	1.27e-05	6.06e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—GNAQ—ocular cancer	1.27e-05	6.05e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—CDK2—ocular cancer	1.26e-05	6.03e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MDM2—ocular cancer	1.26e-05	6.02e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—HRAS—ocular cancer	1.25e-05	5.97e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GNAQ—ocular cancer	1.24e-05	5.95e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CDKN1A—ocular cancer	1.22e-05	5.82e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—EP300—ocular cancer	1.21e-05	5.77e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	1.2e-05	5.71e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	1.18e-05	5.64e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	1.18e-05	5.62e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CDKN1B—ocular cancer	1.16e-05	5.57e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	1.15e-05	5.52e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CDKN1B—ocular cancer	1.15e-05	5.5e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HDAC1—ocular cancer	1.14e-05	5.45e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MDM2—ocular cancer	1.14e-05	5.45e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MDM2—ocular cancer	1.14e-05	5.45e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—MYC—ocular cancer	1.11e-05	5.32e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CCND1—ocular cancer	1.11e-05	5.31e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TGFB1—ocular cancer	1.11e-05	5.31e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—AKT1—ocular cancer	1.1e-05	5.27e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CCND1—ocular cancer	1.1e-05	5.25e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—HRAS—ocular cancer	1.08e-05	5.17e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CDKN1A—ocular cancer	1.07e-05	5.14e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HDAC1—ocular cancer	1.06e-05	5.08e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GNA11—ocular cancer	1.06e-05	5.08e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CDKN1A—ocular cancer	1.06e-05	5.08e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—HRAS—ocular cancer	1.06e-05	5.06e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—HRAS—ocular cancer	1.06e-05	5.06e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CDKN1B—ocular cancer	1.04e-05	4.98e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CDKN1B—ocular cancer	1.04e-05	4.98e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—AKT1—ocular cancer	1.03e-05	4.92e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—EP300—ocular cancer	1.02e-05	4.89e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CDKN2B—ocular cancer	1.02e-05	4.89e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—EP300—ocular cancer	1.01e-05	4.83e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	1e-05	4.8e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CCND1—ocular cancer	9.93e-06	4.75e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CCND1—ocular cancer	9.93e-06	4.75e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GNAQ—ocular cancer	9.88e-06	4.72e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	9.69e-06	4.63e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—HRAS—ocular cancer	9.68e-06	4.62e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CDKN1A—ocular cancer	9.61e-06	4.59e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CDKN1A—ocular cancer	9.61e-06	4.59e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—AKT1—ocular cancer	9.56e-06	4.57e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CDKN2B—ocular cancer	9.54e-06	4.56e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—E2F1—ocular cancer	9.38e-06	4.48e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—AKT1—ocular cancer	9.35e-06	4.47e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—AKT1—ocular cancer	9.35e-06	4.47e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—AKT1—ocular cancer	9.23e-06	4.41e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—EP300—ocular cancer	9.14e-06	4.37e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—EP300—ocular cancer	9.14e-06	4.37e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TP53—ocular cancer	9.14e-06	4.37e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MYC—ocular cancer	8.91e-06	4.26e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TGFB1—ocular cancer	8.89e-06	4.25e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MYC—ocular cancer	8.81e-06	4.21e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—TGFB1—ocular cancer	8.79e-06	4.2e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—MDM2—ocular cancer	8.77e-06	4.19e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—HRAS—ocular cancer	8.74e-06	4.18e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GNA11—ocular cancer	8.65e-06	4.13e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GNA11—ocular cancer	8.6e-06	4.11e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—AKT1—ocular cancer	8.54e-06	4.08e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—AKT1—ocular cancer	8.31e-06	3.97e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—HRAS—ocular cancer	8.26e-06	3.95e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	8.18e-06	3.91e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GNAQ—ocular cancer	8.04e-06	3.84e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CDKN1B—ocular cancer	8.01e-06	3.83e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GNAQ—ocular cancer	8e-06	3.82e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	7.98e-06	3.81e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MYC—ocular cancer	7.97e-06	3.81e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MYC—ocular cancer	7.97e-06	3.81e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TGFB1—ocular cancer	7.95e-06	3.8e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TGFB1—ocular cancer	7.95e-06	3.8e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HRAS—ocular cancer	7.93e-06	3.79e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GNA11—ocular cancer	7.72e-06	3.69e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—AKT1—ocular cancer	7.72e-06	3.69e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GNA11—ocular cancer	7.54e-06	3.6e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CDKN1A—ocular cancer	7.39e-06	3.53e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TP53—ocular cancer	7.32e-06	3.5e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—AKT1—ocular cancer	7.3e-06	3.49e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GNAQ—ocular cancer	7.18e-06	3.43e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—EP300—ocular cancer	7.09e-06	3.39e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GNA11—ocular cancer	7.04e-06	3.36e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—EP300—ocular cancer	7.03e-06	3.36e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GNAQ—ocular cancer	7.01e-06	3.35e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—AKT1—ocular cancer	7.01e-06	3.35e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—HRAS—ocular cancer	7e-06	3.34e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—HRAS—ocular cancer	6.92e-06	3.31e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GNAQ—ocular cancer	6.54e-06	3.13e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TP53—ocular cancer	6.54e-06	3.13e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TP53—ocular cancer	6.54e-06	3.13e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—ocular cancer	6.49e-06	3.1e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—EP300—ocular cancer	6.45e-06	3.08e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HRAS—ocular cancer	6.26e-06	2.99e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HRAS—ocular cancer	6.26e-06	2.99e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—AKT1—ocular cancer	6.18e-06	2.95e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TGFB1—ocular cancer	6.16e-06	2.94e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—AKT1—ocular cancer	6.11e-06	2.92e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—EP300—ocular cancer	5.79e-06	2.77e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MDM2—ocular cancer	5.67e-06	2.71e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—AKT1—ocular cancer	5.52e-06	2.64e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—AKT1—ocular cancer	5.52e-06	2.64e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MDM2—ocular cancer	5.29e-06	2.53e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	5.28e-06	2.52e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CDKN1B—ocular cancer	5.18e-06	2.47e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TP53—ocular cancer	5.07e-06	2.42e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCND1—ocular cancer	4.94e-06	2.36e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—HRAS—ocular cancer	4.85e-06	2.32e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CDKN1B—ocular cancer	4.83e-06	2.31e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HRAS—ocular cancer	4.81e-06	2.3e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CDKN1A—ocular cancer	4.78e-06	2.28e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EP300—ocular cancer	4.55e-06	2.17e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—EP300—ocular cancer	4.47e-06	2.14e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CDKN1A—ocular cancer	4.46e-06	2.13e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—AKT1—ocular cancer	4.28e-06	2.05e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—AKT1—ocular cancer	4.25e-06	2.03e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EP300—ocular cancer	4.24e-06	2.03e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MYC—ocular cancer	3.96e-06	1.89e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TGFB1—ocular cancer	3.95e-06	1.89e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MYC—ocular cancer	3.7e-06	1.77e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TGFB1—ocular cancer	3.69e-06	1.76e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—EP300—ocular cancer	3.55e-06	1.7e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TP53—ocular cancer	3.25e-06	1.55e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HRAS—ocular cancer	3.11e-06	1.49e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HRAS—ocular cancer	2.9e-06	1.39e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—EP300—ocular cancer	2.89e-06	1.38e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—EP300—ocular cancer	2.87e-06	1.37e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—AKT1—ocular cancer	2.75e-06	1.31e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—AKT1—ocular cancer	2.7e-06	1.29e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—EP300—ocular cancer	2.58e-06	1.23e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—AKT1—ocular cancer	2.56e-06	1.22e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—EP300—ocular cancer	2.52e-06	1.2e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—EP300—ocular cancer	2.35e-06	1.12e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—AKT1—ocular cancer	2.15e-06	1.03e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—AKT1—ocular cancer	1.75e-06	8.35e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—AKT1—ocular cancer	1.74e-06	8.3e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—AKT1—ocular cancer	1.56e-06	7.45e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—AKT1—ocular cancer	1.52e-06	7.27e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—AKT1—ocular cancer	1.42e-06	6.79e-06	CbGpPWpGaD
